NanoTherm Nanoparticles

Our iron oxide nanoparticles have an aminosilane coating. Following direct injection of the colloidal liquid into the tissue, the special coating causes the nanoparticles to aggregate and stay in place, making repeated treatments possible.

Injection of NanoTherm Nanoparticles

In a procedure similar to a biopsy, nanoparticles are injected and distributed within tumor.

NanoPlan® Therapy Planning Software

Prior to patient treatment, three-dimensional computer imaging is used to simulate the temperature increase within the tumor.

NanoActivator® Magnetic Field Applicator

An alternating magnetic field that changes its polarity 100,000 times per second activates the nanoparticles and electromagnetic energy is transformed into heat.

MagForce AG is a pioneer in the area of nanotechnology-based cancer treatment. It is the first company in the world to receive European approval for a medical product using nanoparticles. In Germany, this innovative therapy is available to patients at the NanoTherm therapy centers at the Charité-Universitätsmedizin hospital in Berlin, and the university hospitals in Münster and Kiel. Additional therapy centers in Germany are planned for 2014.

The analysts of Berenberg Bank initiated the coverage of MagForce AG with a buy recommendation and a price target of 8,25 €.

Learn more: